Quarterly report pursuant to Section 13 or 15(d)

NET LOSS PER SHARE OF COMMON STOCK (Details Narrative)

v3.22.4
NET LOSS PER SHARE OF COMMON STOCK (Details Narrative) - shares
3 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Share-Based Payment Arrangement, Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 11,821,500 10,700,626
Warrant [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive shares 300,000 360,000